Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes

European Journal of Immunology

Volumn 33, Issue 2, 2003, Pages 411-421

  Brocke, Pascale ^a   Armandola, Elena ^a   Garbi, Natalio ^a   Hämmerling, Günter J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Antigen presentation; H2 O; HLA DO

Indexed keywords

B LYMPHOCYTE RECEPTOR; CHLOROQUINE; HLA DM ANTIGEN; HLA DO ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; B LYMPHOCYTE; CATALYSIS; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; GENE CONSTRUCT; GENE OVEREXPRESSION; HYBRIDOMA; LYMPHOID CELL LINE; LYSOSOME; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL LINE; CHLOROQUINE; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; LYMPHOMA, B-CELL; LYSOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, B-CELL; RECOMBINANT FUSION PROTEINS; RNA, CATALYTIC; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037331965     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200310015     Document Type: Review

References (42)

1. Kropshofer, H., Hämmerling, G. J. and Vogt, A. B., The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 1999. 172: 267-278.
2. Alfonso, C. and Karlsson, L., Nonclassical MHC class II molecules. Annu. Rev. Immunol. 2000. 18: 113-142.
3. Brocke, P., Garbi, N., Momburg, F. and Hämmerling, G. J., HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr. Opin. Immunol. 2002. 14: 22-29.
4. Kropshofer, H., Vogt, A. B., Moldenhauer, G., Hammer, J., Blum, J. S. and Hämmerling, G. J., Editing of the HLA-DR: peptide repertoire by HLA-DM. EMBO J. 1996. 15: 6144-6154.
5. Kropshofer, H., Arndt, S. O., Moldenhauer, G., Hämmerling, G. J. and Vogt, A. B., HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997. 6: 293-302.
6. Fremont, D. H., Crawford, F., Marrack, P. et al., Crystal structure of mouse H2-M. Immunity 1998. 9: 385-393.
7. Mosyak, L., Zaller, D. M. and Wiley, D. C., The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 1998. 9: 377-383.
8. Kropshofer, H., Hämmerling, G. J. and Vogt A. B., How HLA-DM edits the MHC II peptide repertoire: Survival of the fittest? Immunol. Today 1997. 18: 77-82.
9. Weber, D. A., Evavold, B. D. and Jensen, P. E., Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996. 274: 618-620.
10. Verreck, F. A. W., Fargeas, C. A and Hämmerling, G. J., Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM. Eur. J. Immunol. 2001. 31: 1029-1036.
11. Karlsson, L., Surh, C. D., Sprent, J. and Peterson, P. A., A novel class II MHC molecule with unusual tissue distribution. Nature 1991. 351: 485-488.
12. Liljedahl, M., Kuwana, T., Fung-Leung, W.-P., Jackson, M. R., Peterson, P. A. and Karlsson, L., HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 1996. 15: 4817-4824.
13. Douek, D. C. and Altmann, D. M., HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 1989. 9: 355-364.
14. Kropshofer, H., Vogt, A. B., Thery, C., Armandola, E. A., Li, B.C., Moldenhauer, G., Amigorena, S. and Hämmerling, G. J., A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 1998. 17: 2971-2981.
15. van Ham, S. M., Tijn, E. P. M., Lillemeier, B. F., Grüneberg, U., van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., Ottenhoff, T. H. M., Pappin, D. J. C., Trowsdale, J. and Neefjes, J., HLA-DO is a negative modulator of HLA-DM mediated MHC class II peptide loading. Curr. Biol. 1997. 7: 950-957.
16. Qi, L. and Ostrand-Rosenberg, S., H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens. J. Immunol. 2001. 167: 1371-1378.
17. Liljedahl, M., Winqvist, O., Surh, C. D., Wong, P., Ngo, K., Teyton, L., Peterson, P. A., Brunmark, A., Rudensky, A. Y., Fung-Leung, W.-P. and Karlsson, L., Altered antigen presentation in mice lacking H2-O. Immunity 1998. 8: 233-243.
18. Perraudeau, M., Taylor, P. R., Stauss, H. J., Lindstedt, R., Bygrave, A. E., Pappin, D. J., Ellmerich, S., Whitten, A., Rahman, D., Canas, B., Walport, M. J., Botto, M. and Altmann, D. M., Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur. J. Immunol. 2000. 30: 2871-2880.
19. van Ham, S. M., Lith, M., Lillemeier, B., Tjin, E., Grüneberg, U., Rahmann, D., Pastoors, L., van Meijgaarden, K. E., Roucard, C., Trowsdale, J., Ottenhoff, T., Pappin, D. and Neefjes, J., Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA-DO). J. Exp. Med. 2000. 191: 1127-1135.
20. Glazier, K. S., Hake, S. B., Tobin, H. M., Chadburn, A., Schattner, E. J. and Denzin, L. K., Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 2002. 195: 1063-1069.
21. Chen, X., Laur, O., Kambayashi, T., Li, S., Bray, R. A., Weber, D. A., Karlsson, L. and Jensen, P. E., Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 2002. 195: 1053-1062.
22. Birikh, K. R., Heaton, P. A. and Eckstein, F., The hammerhead ribozyme: Structure, function and application. Eur. J. Biochem. 1997. 245: 1-16.
23. Bramlage, B. and Eckstein, F., Das Hammerhead-Ribozym zur Inhibition der Genexpression. BIOforum 1997. 4: 134-137.
24. Arndt, S. O., Vogt, A. B., Markovic-Plese, S., Martin, R., Moldenhauer, G., Wölpl, A., Sun, Y., Schadendorf, D., Hämmerling, G. J. and Kropshofer, H., Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 2000. 19: 1241-1251.
25. Nowell, J., and Quaranta, V., Chloroquine affects biosynthesis of la molecules by inhibiting dissociation of invariant (γ) chains from α-β dimers in B cells. J. Exp. Med. 1985. 162: 1371.
26. van Lith, M., van Ham, M., Griekspoor, A. et al., Regulation ofg MHC class II antigen presentation by sorting of recycling HLA-DM/DO and calss II within the multivesicular body. J. Immunol. 2001. 167: 884-892.
27. Pathak, S. S., Lcih, J. D. and Blum, J. S., Cutting edge: editing of recycling class II: peptide complexes by HLA-DM. J. Immunol. 2001. 167: 622-635.
28. Tonnelle, C., DeMars, R. and Long E. O., DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J. 1985. 4: 2839-2847.
29. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J., Cresswell, P., Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997. 278: 106-109.
30. Kropshofer, H., Spindeldreher, S, Rohn, T. A. et al., Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 2002. 3: 61-68.
31. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. NAtl. Acad. Sci. USA 1982. 79: 3604-3607.
32. Tabler, M. and Tsagris, M., Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA. Gene 1991. 108: 175-183.
33. Karlsson, L., Peleraux, A., Lindstedt, R., Liljedahl, M. and Peterson, P. A., Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 1994. 266: 1569-1573.
34. Janeway, C. A., Conrad, P. J., Lerner, E. A., Babich, J., Wettstein, P. and Murphy, D. B., Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cell bound Ia antigens as targets of immunregulatory T cells. J. Immunol. 1984. 132: 662-667.
35. Murphy, D. B., Rath, S., Pizzo, E., Rudensky, A. Y., George, A., Larson, J. K. and Janeway, C. A., Monoclonal antibody detection of a major self peptide MHC class II complex. J. Immunol. 1992. 148: 3483-3491.
36. Eastman, S., Deftos, M., DeRoos, P. C., Hsu, D.-H. and Teyton, L., Braunstein, N. S., Hackett, C. J. and Rudensky, A., A study of complexes of class II invariant chain peptide: MHC II molecules using a new complex-specific monoclonal antibody. Eur. J. Immunol. 1996. 26: 385-393.
37. Adorini, L., Sette, A., Buus, S., Grey, H. M., Darsley, M., Lehmann, P. V., Doria, G., Nagy, Z. A. and Appella, E., Interaction of an immunodominant epitope with Ia molecules in T cell activation. Proc. Natl. Acad. Sci. USA 1988. 85: 5181-5185.
38. Weenink, S., Averdunk, H., Boston, T., Boswarva, V., Guery, J-C., Adorini, L., Mellins, E., McCluskey, J. and Gautam, A. M., Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. Int. Immunol. 1997. 9: 889-896.
39. Shimonkevitz, R., Kappler, J. W., Marrack, P. and Grey, H. M., Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J. Exp. Med. 1983. 158: 303-316.
40. Sanderson, S. and Shastri, N., LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 1994. 6: 369-376.
41. Wassmer, P., Chan, C., Logdberg, L. and Shevach, E. M., Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. J. Immunol. 1985. 135: 2237-2242.
42. Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A. and Janeway, C. A., Sequence analysis of peptides bound to MHC class II molecules. Nature 1991. 353: 622.